| PRODUCT NAME | HOLDER | STATUS | DATE | INDICATION |
| Caelyx pegylated liposomal | Baxter Holding B.V. | Authorised | 20/06/1996 | Sarcoma, Kaposi;Multiple Myeloma;Ovarian Neoplasms;Breast Neoplasms |
| Zolsketil pegylated liposomal | Accord Healthcare S.L.U. | Authorised | 31/05/2022 | Ovarian Neoplasms;Sarcoma, Kaposi;Multiple Myeloma |
| Myocet liposomal (previously Myocet) | CHEPLAPHARM Arzneimittel GmbH | Authorised | 13/07/2000 | Breast Neoplasms |
| Doxorubicin Hydrochloride Tillomed | Laboratorios Tillomed Spain S.L.U | Application withdrawn | | Breast Neoplasms;Ovarian Neoplasms;Multiple Myeloma;Sarcoma, Kaposi |
| Doxolipad | TLC Biopharmaceuticals B.V. | Refused | | Breast Neoplasms;Ovarian Neoplasms |
| Doxorubicin SUN | Sun Pharmaceutical Industries Europe B.V. | Application withdrawn | | — |